购物车
- 全部删除
- 您的购物车当前为空
VA-K-14 hydrochloride(VAK14 HCl)是一种选择性促甲状腺激素受体 (TSHR) 拮抗剂 (IC50= 12.3 μM),对GD患者血清和单克隆刺激TSHR抗体对TSHR的刺激有抑制作用,可消除 TSHR 信号传导。
为众多的药物研发团队赋能,
让新药发现更简单!
VA-K-14 hydrochloride(VAK14 HCl)是一种选择性促甲状腺激素受体 (TSHR) 拮抗剂 (IC50= 12.3 μM),对GD患者血清和单克隆刺激TSHR抗体对TSHR的刺激有抑制作用,可消除 TSHR 信号传导。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 525 | 现货 | |
5 mg | ¥ 1,280 | 现货 | |
10 mg | ¥ 1,980 | 现货 | |
25 mg | ¥ 3,970 | 现货 | |
50 mg | ¥ 5,790 | 现货 | |
100 mg | ¥ 7,820 | 现货 | |
200 mg | ¥ 10,500 | 现货 |
产品描述 | VA-K-14 hydrochloride(VAK14 HCl) is a selective thyrotropin receptor (TSHR) antagonist (IC50= 12.3 μM) that inhibits TSHR stimulation by serum and monoclonal TSHR-stimulating antibodies from patients with GD and abrogates TSHR signaling. |
靶点活性 | TSHR:12.3 μM |
别名 | VAK14 Hydrochloride, VA K 14 HCl, VA-K-14 HCl, VAK14 HCl |
分子量 | 341.86 |
分子式 | C18H16ClN3S |
CAS No. | 1171341-19-7 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 55 mg/mL (160.88 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.